Elk Creek Partners, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 172 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Elk Creek Partners, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$8,890,000
-27.6%
265,146
-2.2%
1.53%
+8.1%
Q4 2019$12,285,000
-29.5%
271,182
-40.7%
1.41%
-5.7%
Q3 2019$17,422,000
-19.9%
457,637
-8.5%
1.50%
-7.8%
Q2 2019$21,748,000
+1.2%
500,069
-11.4%
1.62%
+4.9%
Q1 2019$21,488,000
-6.8%
564,576
+5.3%
1.55%
-19.1%
Q4 2018$23,067,000
-35.3%
536,194
-26.1%
1.91%
-0.5%
Q3 2018$35,653,000
-18.7%
725,395
-47.0%
1.92%
-20.3%
Q2 2018$43,878,000
+40.5%
1,369,060
+36.6%
2.41%
+32.3%
Q1 2018$31,222,000
+3.5%
1,002,311
+51.7%
1.82%
+2.8%
Q4 2017$30,165,000
+31.3%
660,791
+8.0%
1.77%
+22.6%
Q3 2017$22,982,000
-12.8%
612,049
+10.7%
1.45%
-15.3%
Q2 2017$26,362,000
+4.7%
552,656
+0.1%
1.71%
+10.9%
Q1 2017$25,176,000
+74.0%
552,116
+23.3%
1.54%
+57.6%
Q4 2016$14,466,000
-7.8%
447,857
-2.3%
0.98%
-5.4%
Q3 2016$15,688,000
+7.0%
458,448
+5.5%
1.03%
-1.1%
Q2 2016$14,662,000
-29.0%
434,699
+11.6%
1.04%
-31.5%
Q1 2016$20,639,000
-22.0%
389,558
+13.0%
1.53%
-19.0%
Q4 2015$26,477,000
+72.3%
344,800
-7.8%
1.88%
+51.8%
Q3 2015$15,366,000
+203.0%
373,873
+421.4%
1.24%
+173.0%
Q2 2015$5,071,00071,7000.46%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders